Establishment of a surgically-induced model in mice to investigate the protective role of progranulin in osteoarthritis

Journal of Visualized Experiments

Volumn , Issue 84, 2014, Pages

  Zhao, Yunpeng ^a   Liu, Ben ^a   Liu, Chuan Ju ^b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bioengineering; Cartilage; Degenerative arthritis; Destabilization of medial meniscus (DMM); Issue 84; Mouse; Osteoarthritis; Progranulin; Surgery

Indexed keywords

GRN PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; GENE INACTIVATION; GENETICS; KNEE MENISCUS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OSTEOARTHRITIS;

ANIMALS; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MENISCI, TIBIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOARTHRITIS;

EID: 84904539004     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/50924     Document Type: Article

References (29)

1. Herndon, J. H., Davidson, S. M. &Apazidis, A. Recent socioeconomic trends in orthopaedic practice. J. Bone Joint Surg. Am. 83-A, 1097-1105 (2001).
2. Johnson, K. et al. A stem cell-based approach to cartilage repair. Science. 336, 717-721, doi:10.1126/science.1215157 (2012).
3. Yang, S. et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat. Med. 16, 687-693, doi:10.1038/nm.2153 (2010).
4. Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 434, 644-648 (2005).
5. Glasson, S. S., Blanchet, T. J. & Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr. Cart.15, 1061-1069, doi:10.1016/j.joca.2007.03.006 (2007).
6. Chia, S. L. et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60, 2019-2027 (2009).
7. Miller, R. E. et al. CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis. Proc. Natl. Acad. Sci. U.S.A. 109, 20602-20607, doi:10.1073/pnas.1209294110 (2012).
8. Wang, Q. et al. Identification of a central role for complement in osteoarthritis. Nat. Med. 17, 1674-1679, doi:10.1038/nm.2543 (2011).
9. He, Z., Ong, C. H., Halper, J. & Bateman, A. Progranulin is a mediator of the wound response. Nat. Med. 9, 225-229 (2003).
10. Bateman, A. & Bennett, H. P. The granulin gene family: from cancer to dementia. Bioessays. 31, 1245-1254, doi:10.1002/bies.200900086 (2009).
11. Kessenbrock, K. et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatoryprogranulin. J. Clin. Invest. 118, 2438-2447 (2008).
12. Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 207, 117-128 (2010).
13. Liu, C. J. Progranulin: A promising therapeutic target for rheumatoid arthritis. FEBS Lett. May 4 (2011).
14. Tang, W. et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 332, 478-484, doi:10.1126/science.1199214 (2011).
15. Zhu, J. et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 111, 867-878 (2002).
16. Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442, 916-919 (2006).
17. Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 442, 920-924 (2006).
18. Wils, H. et al. Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice. J. Pathol. doi:10.1002/path.4043 (2012).
19. Guo, F. et al. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum. 62, 2023-2036, doi:10.1002/art.27491 (2010).
20. Xu, K. et al. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation.J. Biol. Chem. 282, 11347-11355 (2007).
21. Bai, X. H. et al. ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor. Mol. Cell. Biol. 29, 4201-4219, doi:10.1128/mcb.00056-09 (2009).
22. Feng, J. Q. et al. Granulinepithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 24, 1879-1892 (2010).
23. Liu, C. J. & Bosch, X. Progranulin: A growth factor, a novel TNFR ligand and a drug target. Pharmacol. Therap. 133, 124-132 (2012).
24. Wu, H. & Siegel, R. M. Progranulin Resolves Inflammation. Science. 332, 427-428 (2011).
25. Glasson, S. S., Chambers, M. G., Van Den Berg, W. B. & Little, C. B. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cart. 18 Suppl 3, S17-23, doi:10.1016/j.joca.2010.05.025 (2010).
26. Glasson, S. S. In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr. Drug Targets. 8, 367-376 (2007).
27. Ma H. L. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthr. Cart. 15, 695-700 (2007).
28. Lin, A. C. et al. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat. Med. 15, 1421-1425, doi:10.1038/nm.2055 (2009).
29. Malfait, A. M. et al. ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization. Osteoarthr. Cart. 18, 572-580 (2010).